The Lancet Respiratory Medicine in conversation with Podcast Por The Lancet Group arte de portada

The Lancet Respiratory Medicine in conversation with

The Lancet Respiratory Medicine in conversation with

De: The Lancet Group
Escúchala gratis

Editors at The Lancet Respiratory Medicine, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.

A monthly audio companion to the journal, this podcast covers a broad range of topics, from long COIVD outcomes to tobacco control, the management of uncontrolled asthma to intensive care medicine, and more.

© 2025 The Lancet Group Ciencia Ciencias Biológicas Enfermedades Físicas Higiene y Vida Saludable
Episodios
  • Carole Mitnick & Lorenzo Guglielmetti on the ENDTB-Q trial

    Carole Mitnick & Lorenzo Guglielmetti on the ENDTB-Q trial
    Jul 16 2025

    Carole Mitnick & Lorenzo Guglielmetti join Ari Colosio, deputy editor of The Lancet Respiratory Medicine, to discuss the ENDTB-Q trial to evaluate the efficacy and safety of a drug regiment to treat TB in individuals with pre-extensively drug-resistant tuberculosis.

    Read the full article:

    https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00194-8/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanres

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Más Menos
    19 m
  • Lorenzo Guglielmetti parla del trial clinico ENDTB-Q (in Italian)

    Lorenzo Guglielmetti parla del trial clinico ENDTB-Q (in Italian)
    Jul 16 2025

    This episode is in Italian. For the English version, please see the main feed.

    Lorenzo Guglielmetti sul trial clinico ENDTB-Q per valutare l’efficacia e la sicurezza di un regime di farmaci per curare la tubercolosi in individui con tubercolosi pre-estesa farmaco-resistente.

    Leggi l'articolo completo:

    https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00194-8/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanres

    Continue this conversation on social!
    Follow us today at...
    https://thelancet.bsky.social/
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv
    Más Menos
    15 m
Todavía no hay opiniones